Expecting another child can be both exciting and nerve-racking. Many parents feel more confident the second (or third) time ...
Almost half a century on from the first ‘test tube’ birth, IVF has been used by millions – yet some fear it heralds a ...
Canadian officials show that reviewing emerging supply chain issues and taking steps to limit potential problems worked in its favor. Also in the news: noncompete bans, schizophrenia drugs, baby ...
Researchers have developed a novel delivery system for sending CRISPR reagents to brain cells, where it performs its gene ...
Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...
The study, led by Erin Von Klein, MD, a neonatology fellow at Monroe Carell Jr. Children's Hospital at Vanderbilt, reveals that 30% of parents with a very low birth weight baby (under 1,500 grams ...
Amsterdam police say they have found a prematurely born baby who was abducted from the maternity ward of a Paris-region hospital earlier this week AMSTERDAM -- A prematurely born baby who was ...
Editas Medicine also said it plans to seek a partner to continue the development of its CRISPR-based treatment for sickle cell ... compared to just 26% of Baby Boomers. Sangamo is set to seek ...
NTLA-2002 is an in vivo gene-editing therapy that is based on clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9. NTLA-2002 targets the gene encoding ...
Intellia Therapeutics has taken another step toward its goal of winning the first approval for an in vivo CRISPR therapy, linking its hereditary angioedema (HAE) prospect to an 81% reduction in ...
Lil Baby’s Ayesha Howard announced the birth of her daughter via Instagram on Tuesday night. Howard took to social media to gush over her “doll baby” with a carousel of photos captioned ...
Labroots invites you to the 7th Annual Event in the CRISPR Virtual Event Series 2024 taking place on October 23rd, 2024! This event will continue the conversation of the abilities of CRISPR-based ...